Health Condition 1: null- breast cancer
Conditions
Interventions
Intervention1: study of the evaluation of postoperative analgesia after modified radical mastectomy by surgical site infiltration with either bupivacaine alone or with dexmedetomidine: to evaluate pos
Sponsors
Monisha B J Neelankavil
Eligibility
Inclusion criteria
Inclusion criteria: breast cancer patients undergoing modified radical mastectomy
Exclusion criteria
Exclusion criteria: Known hypersensitivity or contraindication to Bupivacaine or Dexmedetomidine; pregnancy, drug allergy, cardiac patients, renal patients, significant pulmonary diseases, bleeding diathesis, psychological, neurological, metabolic diseases,Chronic analgesic drug abuse (on oral analgesics for more than a month).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To compare the postoperative analgesic effects of bupivacaine following mastectomy 2)To compare the postoperative analgesic effects of dexmedetomidine following mastectomy 3)To compare the postoperative analgesic effect of Bupivacaine combined with Dexmedetomidine following mastectomy. 4)To compare the requirement of analgesics following mastectomy between the two groups for 24 hours Timepoint: visual analogue score of more than 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)To compare the postoperative analgesic effects of bupivacaine following mastectomy 2)To compare the postoperative analgesic effects of dexmedetomidine following mastectomy 3)To compare the postoperative analgesic effect of Bupivacaine combined with Dexmedetomidine following mastectomy. 4)To compare the requirement of analgesics following mastectomy between the two groups for 24 hours Timepoint: ramsay sedation scale of 2 or 3 modified aldrete score more than 9 | — |
Countries
India
Contacts
Public ContactDr Shailaja S
father muller charitable institutions
Outcome results
None listed